Latest News
From the Journals
Nuedexta mainly prescribed for dementia, Parkinson’s
Only 15.2% of patients had multiple sclerosis or amyotrophic lateral sclerosis, the diagnoses of patients in the studies leading to the approval...
Latest News
Does rituximab delay disability progression in patients with secondary progressive MS?
Patients with secondary progressive MS who are treated with rituximab off label may accrue less disability during follow-up, compared with matched...
Latest News
Integrated analysis suggests cladribine’s safety in MS
Cladribine is not associated with an increased risk of infections or malignancy, and treatment-induced lymphopenia is transient.
News from the FDA/CDC
Synthetic opioids drive spike in U.S. fatal drug overdoses
Spurned by physicians, more users seem to be turning to street drugs that contain fentanyl and similar substances.
From the Journals
Prenatal valproate exposure raises ADHD risk
Children whose mothers took valproate during pregnancy were significantly more likely to have ADHD diagnoses.
From the Journals
Cerebral small vessel disease progression linked to MCI in hypertensive patients
From the Journals
EHR stress linked to burnout
Almost two-thirds of respondents “agreed” or “strongly agreed” that EHRs add to the frustration of their day.
FDA/CDC
With hemp now legal, FDA reaffirms rules for cannabis compounds
Latest News
Can higher MAP post cardiac arrest improve neurologic outcomes?
CHICAGO – A target mean arterial pressure higher than what the guidelines recommend appears safe but has mixed results for improving neurologic...
Latest News
Healthcare.gov activity surged in last week of open enrollment
Total number of plans selected more than doubled during week 7.
Latest News
Next legal ruling on ACA could come on New Year’s Eve
In general, Mr. Jost said that he does not expect Judge O’Connor’s ruling to stand.